Literature DB >> 16891650

Crescentic glomerulonephritis and malignancy--guilty or guilt by association?

Sibylle von Vietinghoff1, Wolfgang Schneider, Friedrich C Luft, Ralph Kettritz.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16891650     DOI: 10.1093/ndt/gfl456

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  A Case of Colon Cancer and Pauci-Immune Crescentic Glomerulonephritis.

Authors:  David Wilhelm; Dawn Caster; Susan Coventry; Gunjan Garg
Journal:  Cureus       Date:  2022-07-29

2.  Effect of RAAS inhibition on the incidence of cancer and cancer mortality in patients with glomerulonephritis.

Authors:  Ho Jun Chin; Se Won Oh; Ho Suk Goo; Jieun Oh; Jung Woo Noh; Jong Tae Cho; Ki Young Na; Suhnggwon Kim; Dong-Wan Chae
Journal:  J Korean Med Sci       Date:  2010-12-22       Impact factor: 2.153

3.  Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis and Malignancy: A Case of a Patient Diagnosed with Renal Failure and Pulmonary Carcinoma Concurrently.

Authors:  Maki Asakura; Tetsu Akimoto; Ken Ohara; Takahiro Masuda; Yuko Ono; Osamu Saito; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2021-03-28

4.  Nephrotic syndrome associated with metastatic melanoma: a case report.

Authors:  Fabiana Almeida Antonio Bienes; Germana Alves de Brito; Joubert Araujo Alves; Aline Lourenco Baptista; Luis André Silvestre Andrade; Marina Harume Imanishe; Benedito Jorge Pereira
Journal:  Clin Case Rep       Date:  2022-03-11

5.  Discovering disease-disease associations by fusing systems-level molecular data.

Authors:  Marinka Žitnik; Vuk Janjić; Chris Larminie; Blaž Zupan; Nataša Pržulj
Journal:  Sci Rep       Date:  2013-11-15       Impact factor: 4.379

6.  Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy.

Authors:  Jiwon Ryu; HyunJin Ryu; Sejoong Kim; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Hyung-Jin Yoon
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.